Skipping routine radiation for advanced lung cancer after immunotherapy and chemo
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether it is safe to skip routine radiation to the tumor bed in patients with stage III lung cancer that has responded well to immunotherapy and chemotherapy. It aims to reduce side effects while still controlling the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer (a common type of lung cancer).
- Your cancer is stage IIIA, IIIB, or IIIC (has spread to nearby lymph nodes but not elsewhere).
- You cannot have surgery or choose not to after initial treatment with immunotherapy and chemotherapy.
- After at least 2 cycles of induction chemo-immunotherapy, your scans show the cancer shrank or didn't grow.
- You are in good general health (able to care for yourself, with no serious heart, lung, or other problems).
- Your tumor does not have mutations in EGFR, ALK, or ROS1 genes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This trial is testing whether giving radiation therapy after surgery can help prevent lung cancer from coming back in people who have already had chemotherapy and immunotherapy before surgery. It is for patients whose cancer had spread to chest lymph nodes and who still have some cancer left in those nodes after surgery.
This trial tests whether giving focused radiation to remaining spots of lung cancer (after standard treatment) can help prevent cancer from growing back. It may be an option if you have had 4-6 cycles of chemo plus immunotherapy and still have a few active spots.
This trial tests a new approach for people with stage III lung cancer that cannot be removed with surgery. You would receive immunotherapy (to help your immune system fight cancer) plus chemotherapy first, then standard chemo-radiation, and finally more immunotherapy. The goal is to see if this sequence works better than standard treatment.
This trial tests whether focusing radiation only on the main tumor (not the surrounding area) is safe and effective for people with stage 3 lung cancer that cannot be removed with surgery. It aims to reduce side effects while keeping the treatment working.
This study checks if people with early-stage non-small cell lung cancer can safely skip chemotherapy or radiation after surgery when repeated blood tests show no sign of cancer left. You would only be watched with regular scans and blood tests to make sure the cancer doesn't come back.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.